In addition, we demonstrated that CPZ inhibited the growth/survival of the non-small cell lung cancer cell line, PC9 harboring an activating mutation (exon 19 deletion) in the epidermal growth factor receptor (EGFR) gene [39]. This evidence concerns the gene CPZ and non-small cell lung carcinoma.